Superworth

Faeth Therapeutics EPS FTH

Diluted earnings per share by quarter and over the last twelve months, from 2020.

Last 12 months, to Jun 30, 2026
−$141.65
Latest quarter, Q2 FY26
−$2.84
Fiscal year 2025
−$16.72

Faeth Therapeutics' earnings per share was −$141.65 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$2.84.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$16.72n/a
FY2024−$24.04n/a
FY2023−$24.40n/a
FY2022−$31.60n/a
FY2021−$27.40n/a
FY2020−$256.20n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$2.84n/a−$141.65
Q1 FY26−$131.45n/a−$142.72
Q4 FY25−$3.74n/a−$16.72
Q3 FY25−$3.62n/a−$19.16
Q2 FY25−$3.91n/a−$21.31
Q1 FY25−$5.45n/a−$23.09
Q4 FY24−$6.18n/a−$24.04
Q3 FY24−$5.77n/a−$23.86
Q2 FY24−$5.69n/a−$23.69
Q1 FY24−$6.40n/a−$24.20
Q4 FY23−$6.00n/a−$24.40
Q3 FY23−$5.60n/a−$26.40

Against its peers

Companies in Drug Manufacturers - General nearest Faeth Therapeutics' size, closest first, today.

CompanyEPS, 12 monthsGrowth
FTHFaeth Therapeutics−$141.65
ARVNArvinas$0.16
PBYIPuma Biotechnology$0.52−47% a year
IRWDIronwood Pharmaceuticals$0.77
ZVRAZevra Therapeutics$0.93
CRMDCorMedix$2.13+184% a year
COLLCollegium Pharmaceutical$1.24+19% a year
ABUSArbutus Biopharma$0.78
NATRNatures Sunshine Products$1.01+36% a year
AMPHAmphastar Pharmaceuticals$1.70−36% a year
OMEROmeros$1.52
Peer median$0.97

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Faeth Therapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.